Axsome Therapeutics Inc buy geldnutzer
Start price
03.12.24
/
60%
€96.00
Target price
03.12.25
€129.00
Performance (%)
31.30%
End price
04.12.25
€126.05
Summary
This prediction ended on 04.12.25 with a price of €126.05. The BUY prediction by geldnutzer for Axsome Therapeutics Inc saw massive gains of 31.30%. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Axsome Therapeutics Inc | -1.483% | -1.483% | 40.091% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to geldnutzer what are the pros and cons of Axsome Therapeutics Inc for the foreseeable future?
Pros
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Normal challenges to pay loans and raise capital
Capable Management
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Future proof or reliable business model
Revenue growth >5% per year expected
Standard Investments for future growth
ROE higher than 10% per year
Innovative
Could be worthwhile Investment >10% per year
Good culture
Cons
Sustainability is little important
high free float
Higher risks for its business
Significant cyclical dependencies
Little known brand
Risky balance sheet
Low dividend yield expected
Comments by geldnutzer for this prediction
In the thread Axsome Therapeutics Inc diskutieren
Buy mit Kursziel 126,0
Kursziel geändert auf 106,0
Kursziel geändert auf 126,0
Kursziel geändert auf 106,0
Kursziel geändert auf 109,0
Kursziel geändert auf 129,0
In the thread Trading Axsome Therapeutics Inc
Die von geldnutzer gewählte maximale Laufzeit wurde überschritten